Single center analysis of the first 304 living donor liver transplantations in 3 years

dc.contributor.authorYılmaz, Sezai
dc.contributor.authorKayaalp, Cüneyt
dc.contributor.authorAra, Cengiz
dc.contributor.authorYılmaz, Sezai
dc.contributor.authorIşık, Burak
dc.contributor.authorÖzgör, Dinçer
dc.contributor.authorDinçer, Özgür
dc.contributor.authorBurçin, Ayşe
dc.contributor.authorÜnal, Bülent
dc.contributor.authorPişkin, Turgut
dc.contributor.authorSelimoğlu, Mukadder Ayşe
dc.contributor.authorHarputluoğlu, Muhsin Murat Muhip
dc.contributor.authorKarabiber, Hamza
dc.contributor.authorYalçın, Kendal
dc.contributor.authorKırımlıoğlu, Vedat
dc.date.accessioned2018-02-06T12:30:24Z
dc.date.available2018-02-06T12:30:24Z
dc.date.issued2013
dc.departmentİnönü Üniversitesien_US
dc.descriptionHepatogastroenterology. 2013 Jul-Aug;60(125):1105-9.en_US
dc.description.abstractBACKGROUND/AIMS: Living donor liver transplantations (LDLT) is a definitive treatment for patients with end-stage liver disease (ESLD), especially in the countries with donation problem. Between April 2007 and April 2010, we performed LDLT in 289 patients. Fifteen of the cases required re-transplantations. This study evaluates these 304 consecutive LDLTs donor and recipient outcomes. METHODOLOGY: Complication rates and survival data of the recipients and donors of 304 LDLT cases were analyzed. RESULTS: All donors are alive and well. Overall complication rate was 27%. Early postoperative recipient complication rate was 51%. Most frequent complication was infection. In the long-term there were 57 biliary stricture and 5 chronic bile fistula cases. Chronic and acute rejection attacks developed in 7 and 103 patients, respectively. Hepatic artery thrombosis rate was 8%. One, two and three year survival rates were 82%, 79% and 75%, respectively. Recipient mortality was 25%, mostly due to vascular complications, septic complications, liver dysfunction and chronic rejection. CONCLUSIONS: More than 150 liver tranplantations per year in a single center is a challenge in Turkey, where there is a shortage of deceased donor grafts. LDLT is a safe procedure for donors and effective for ESLD. Improvement in surgical technique would provide better outcomes.en_US
dc.identifier.citationYılmaz, S., Kayaalp, C., Ara, C., Yılmaz, M., Işık, B., Aydın, C., … Ateş, M. (2013). Single Center Analysis Of The First 304 Living Donor Liver Transplantations İn 3 Years. Hepatogastroenterology, 0–0.en_US
dc.identifier.endpage0en_US
dc.identifier.issue0en_US
dc.identifier.startpage0en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pubmed/23478145
dc.identifier.urihttps://hdl.handle.net/11616/8045
dc.identifier.volume0en_US
dc.language.isoenen_US
dc.publisherHepatogastroenterologyen_US
dc.relation.ispartofHepatogastroenterologyen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleSingle center analysis of the first 304 living donor liver transplantations in 3 yearsen_US
dc.typeArticleen_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: